Literature DB >> 8332566

Cognitive deficits in schizophrenia.

J M Gold1, P D Harvey.   

Abstract

There is accumulating evidence that impairment of neuropsychological and basic information processing abilities is an important feature of schizophrenia. Despite the size of this literature and persistent controversy on many specific points, there are several key reliable findings that are relevant to everyday clinical practice. First, impaired cognition is a fundamental aspect of the illness. It can be detected in nearly every case when appropriate controls are used and is often present from before the onset of major signs of the illness. Impairment of most functions is stable even in the face of clinical-symptomatic change. Thus, impairment is not an epiphenomenal feature of symptomatic state, although it is probably a good measure of the overall severity of the illness. In contrast to the perspective of many clinicians, the florid symptoms of schizophrenia are quite unlikely to be the cause of most cognitive deficits. Impairments of attention, memory, and problem solving appear to have particular neurobiologic significance. Although impairments of these functions are not diagnostic of schizophrenia, they are observed frequently and provide converging evidence that schizophrenia is fundamentally an illness of the brain and that cognitive impairment is a symptom domain in its own right, with as much importance for understanding and treating the disorder as positive or negative behavioral symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8332566

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  49 in total

1.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Cognitive effects of olanzapine treatment in schizophrenia.

Authors:  Susan R McGurk; M A Lee; K Jayathilake; Herbert Y Meltzer
Journal:  MedGenMed       Date:  2004-05-10

3.  Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Authors:  Arielle W Tolman; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2010-07-11       Impact factor: 9.306

Review 4.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

Review 5.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

6.  Dysfunctional Activation of the Cerebellum in Schizophrenia: A Functional Neuroimaging Meta-Analysis.

Authors:  Jessica A Bernard; Vijay A Mittal
Journal:  Clin Psychol Sci       Date:  2015-07-01

Review 7.  Cognitive rehabilitation for people with schizophrenia and related conditions.

Authors:  R L Hayes; J J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.

Authors:  R A E Honey; G D Honey; C O'Loughlin; S R Sharar; D Kumaran; E T Bullmore; D K Menon; T Donovan; V C Lupson; R Bisbrown-Chippendale; P C Fletcher
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

Review 9.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

10.  Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?

Authors:  Emre Bora; Robin M Murray
Journal:  Schizophr Bull       Date:  2013-06-14       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.